High lactate dehydrogenase level is associated with an adverse outlook in autografting for Hodgkin's disease. [electronic resource]
Producer: 19960911Description: 383-8 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Carmustine -- therapeutic use
- Combined Modality Therapy
- Cytarabine -- therapeutic use
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Hodgkin Disease -- blood
- Humans
- L-Lactate Dehydrogenase -- blood
- Male
- Melphalan -- therapeutic use
- Middle Aged
- Podophyllotoxin -- therapeutic use
- Prognosis
- Recurrence
- Survival Rate
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.